Different Grey Matter Microstructural Patterns in Cognitively Healthy Versus Typical Ageing Healthy Versus Typical Brain Ageing
Language English Country Great Britain, England Media print
Document type Journal Article, Comparative Study
Grant support
CZ.02.01.01/00/22_008/0004643
Brain Dynamics
P41 EB027061
NIBIB NIH HHS - United States
P41 EB027061
NIH HHS - United States
U01 AG052564
NIA NIH HHS - United States
R01 AG055591
NIA NIH HHS - United States
R01 AG055591
NIH HHS - United States
MH CZ-DRO-VFN64165
General University Hospital in Prague
Charles University, Czech Republic
U01AG052564
NIH HHS - United States
PubMed
39667399
PubMed Central
PMC11637651
DOI
10.1002/nbm.5305
Knihovny.cz E-resources
- Keywords
- HCP‐A, MRI, healthy ageing, typical ageing,
- MeSH
- Cognition * physiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Brain diagnostic imaging MeSH
- Gray Matter * diagnostic imaging MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Aging * physiology MeSH
- Healthy Aging physiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Ageing is a complex phenomenon affecting a wide range of coexisting biological processes. The homogeneity of the studied population is an essential parameter for valid interpretations of outcomes. The presented study capitalises on the MRI data available in the Human Connectome Project-Aging (HCP-A) and, within individuals over 55 years of age who passed the HCP-A section criteria, compares a subgroup of 37 apparently neurocognitively healthy individuals selected based on stringent criteria with 37 age and sex-matched individuals still representative of typical ageing but who did not pass the stringent definition of neurocognitively healthy. Specifically, structural scans, diffusion weighted imaging and T1w/T2w ratio were utilised. Furthermore, data of 26 HCP-A participants older than 90 years as notional 'super-agers' were analysed. The relationship of age and several microstructural MRI metrics (T1w/T2w ratio, mean diffusivity, intracellular volume fraction and free water volume fraction) differed significantly between typical and healthy ageing cohort in areas highly relevant for ageing such as hippocampus, prefrontal and temporal cortex and cerebellum. However, the trajectories of the healthy ageing population did not show substantially better overlap with the findings in people older than 90 than those of the typical population. Therefore, caution must be exercised in the choice of adequate study group characteristics relevant for respective ageing-related hypotheses. Contrary to typical ageing group, the healthy ageing cohort may show generally stable levels of several MRI metrics of interest.
Center for Magnetic Resonance Research University of Minnesota Minneapolis Minnesota USA
Department of Cybernetics Czech Technical University Prague Prague Czech Republic
Department of Neurology University of Minnesota Medical School Minneapolis Minnesota USA
Department of Psychiatry University of Minnesota Medical School Minneapolis Minnesota USA
Department of Radiology University of Minnesota Minneapolis Minnesota USA
Division of Biostatistics School of Public Health University of Minnesota Minneapolis Minnesota USA
See more in PubMed
Martin C. R., Preedy V. R., and Rajendram R., Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and Diet (San Diego, CA: Academic Press, 2021).
Costantino S., Paneni F., and Cosentino F., “Ageing, Metabolism and Cardiovascular Disease,” Journal of Physiology 594, no. 8 (2016): 2061–2073. PubMed PMC
de Roos A., van der Grond J., Mitchell G., and Westenberg J., “Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular‐Driven Disease?,” Circulation 135, no. 22 (2017): 2178–2195. PubMed PMC
Carnevale L., D'Angelosante V., Landolfi A., et al., “Brain MRI Fiber‐Tracking Reveals White Matter Alterations in Hypertensive Patients Without Damage at Conventional Neuroimaging,” Cardiovascular Research 114, no. 11 (2018): 1536–1546. PubMed
Raz N., Rodrigue K. M., and Acker J. D., “Hypertension and the Brain: Vulnerability of the Prefrontal Regions and Executive Functions,” Behavioral Neuroscience 117, no. 6 (2003): 1169–1180. PubMed
Salthouse T. A., “Selective Review of Cognitive Aging,” Journal of the International Neuropsychological Society 16, no. 5 (2010): 754–760. PubMed PMC
MacDonald M. E. and Pike G. B., “MRI of Healthy Brain Aging: A Review,” NMR in Biomedicine 34, no. 9 (2021): e4564. PubMed
Kamiya K., Hori M., and Aoki S., “NODDI in Clinical Research,” Journal of Neuroscience Methods 346 (2020): 108908. PubMed
Filip P., Kokošová V., Valenta Z., et al., “Utility of Quantitative MRI Metrics in Brain Ageing Research,” Frontiers in Aging Neuroscience 15 (2023): 15. PubMed PMC
Bookheimer S. Y., Salat D. H., Terpstra M., et al., “The Lifespan Human Connectome Project in Aging: An Overview,” NeuroImage 185 (2019): 335–348. PubMed PMC
Harms M. P., Somerville L. H., Ances B. M., et al., “Extending the Human Connectome Project Across Ages: Imaging Protocols for the Lifespan Development and Aging Projects,” NeuroImage 183 (2018): 972–984. PubMed PMC
Beaulieu C., “The Biological Basis of Diffusion Anisotropy,” in Diffusion MRI (San Diego, CA: Elsevier, 2014): 155–183.
Christensen K. J., Moye J., Armson R. R., and Kern T. M., “Health Screening and Random Recruitment for Cognitive Aging Research,” Psychology and Aging 7, no. 2 (1992): 204–208. PubMed PMC
McCarten J. R., “Clinical Evaluation of Early Cognitive Symptoms,” Clinics in Geriatric Medicine 29, no. 4 (2013): 791–807. PubMed
Chételat G., La Joie R., Villain N., et al., “Amyloid Imaging in Cognitively Normal Individuals, At‐Risk Populations and Preclinical Alzheimer's Disease,” NeuroImage Clinical 2 (2013): 356–365. PubMed PMC
Ho D., Imai K., King G., and Stuart E. A., “MatchIt: Nonparametric Preprocessing for Parametric Causal Inference,” Journal of Statistical Software 42 (2011): 1–28.
Glasser M. F., Sotiropoulos S. N., Wilson J. A., et al., “The Minimal Preprocessing Pipelines for the Human Connectome Project,” NeuroImage 80 (2013): 105–124. PubMed PMC
Glasser M. F., Coalson T. S., Robinson E. C., et al., “A Multi‐Modal Parcellation of Human Cerebral Cortex,” Nature 536, no. 7615 (2016): 171–178. PubMed PMC
Robinson E. C., Jbabdi S., Glasser M. F., et al., “MSM: A New Flexible Framework for Multimodal Surface Matching,” NeuroImage 100 (2014): 414–426. PubMed PMC
Ji J. L., Spronk M., Kulkarni K., Repovš G., Anticevic A., and Cole M. W., “Mapping the Human Brain's Cortical‐Subcortical Functional Network Organization,” NeuroImage 15, no. 185 (2019): 35–57. PubMed PMC
Winkler A. M., Ridgway G. R., Webster M. A., Smith S. M., and Nichols T. E., “Permutation Inference for the General Linear Model,” NeuroImage 92 (2014): 381–397. PubMed PMC
Benjamini Y. and Hochberg Y., “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing,” Journal of the Royal Statistical Society: Series B: Methodological 57, no. 1 (1995): 289–300.
Oschwald J., Guye S., Liem F., et al., “Brain Structure and Cognitive Ability in Healthy Aging: A Review on Longitudinal Correlated Change,” Reviews in the Neurosciences 31, no. 1 (2020): 1–57. PubMed PMC
Del Brutto O. H., Mera R. M., Zambrano M., Soriano F., and Lama J., “Global Cortical Atrophy (GCA) Associates With Worse Performance in the Montreal Cognitive Assessment (MoCA). A Population‐Based Study in Community‐Dwelling Elders Living in Rural Ecuador,” Archives of Gerontology and Geriatrics 60, no. 1 (2015): 206–209. PubMed
Mariani E., Monastero R., and Mecocci P., “Mild Cognitive Impairment: A Systematic Review,” Journal of Alzheimer's Disease 12, no. 1 (2007): 23–35. PubMed
Petersen R. C., Wiste H. J., Weigand S. D., et al., “ nia‐aa Alzheimer's Disease Framework: Clinical Characterization of Stages,” Annals of Neurology 89, no. 6 (2021): 1145–1156. PubMed PMC
Möller H. E., Bossoni L., Connor J. R., et al., “Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology,” Trends in Neurosciences 42, no. 6 (2019): 384–401. PubMed
Palombo M., Ianus A., Guerreri M., et al., “SANDI: A Compartment‐Based Model for Non‐Invasive Apparent Soma and Neurite Imaging by Diffusion MRI,” NeuroImage 215 (2020): 116835. PubMed PMC
Stüber C., Morawski M., Schäfer A., et al., “Myelin and Iron Concentration in the Human Brain: A Quantitative Study of MRI Contrast,” NeuroImage 93 (2014): 95–106. PubMed
Glasser M. F. and Van Essen D. C., “Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1‐ and T2‐Weighted MRI,” Journal of Neuroscience: The Official Journal of the Society for Neuroscience 31, no. 32 (2011): 11597–11616. PubMed PMC
Filip P., Svatkova A., Carpenter A. F., et al., “Rotating Frame MRI Relaxations as Markers of Diffuse White Matter Abnormalities in Multiple Sclerosis,” NeuroImage: Clinical 26 (2020): 102234. PubMed PMC
Potvin O., Duchesne S., and Dieumegarde L., “T1w/T2w MRI Ratio Brain Signature Across Degenerative Syndromes and Their Cognitive Impairment Continuum and Mixed Presentations,” Alzheimer's & Dementia 19, no. S16 (2023): e073778.
Sui Y. V., Masurkar A. V., Rusinek H., Reisberg B., and Lazar M., “Cortical Myelin Profile Variations in Healthy Aging Brain: A T1w/T2w Ratio Study,” NeuroImage 264 (2022): 119743. PubMed PMC
Cox S. R., Ritchie S. J., Tucker‐Drob E. M., et al., “Ageing and Brain White Matter Structure in 3,513 UK Biobank Participants,” Nature Communications 7, no. 1 (2016): 13629. PubMed PMC
Slater D. A., Melie‐Garcia L., Preisig M., Kherif F., Lutti A., and Draganski B., “Evolution of White Matter Tract Microstructure Across the Life Span,” Human Brain Mapping 40, no. 7 (2019): 2252–2268. PubMed PMC
Filip P., Gallea C., Lehéricy S., Lungu O., and Bareš M., “Neural Scaffolding as the Foundation for Stable Performance of Aging Cerebellum,” Cerebellum 18, no. 3 (2019): 500–510, 10.1007/s12311-019-01015-7. PubMed DOI
Filip P. and Bareš M., “Cerebellum—Aging of the Neuronal Machine,” in Factors Affecting Neurological Aging (San Diego, CA: Elsevier, 2021): 281–288.
Freitas S., Simões M. R., Alves L., and Santana I., “Montreal Cognitive Assessment: Influence of Sociodemographic and Health Variables,” Archives of Clinical Neuropsychology 27, no. 2 (2012): 165–175. PubMed
Weiskopf N., Edwards L. J., Helms G., Mohammadi S., and Kirilina E., “Quantitative Magnetic Resonance Imaging of Brain Anatomy and in Vivo Histology,” Nature Reviews Physics 3, no. 8 (2021): 570–588.
Farrell M. E., Jiang S., Schultz A. P., et al., “Defining the Lowest Threshold for Amyloid‐PET to Predict Future Cognitive Decline and Amyloid Accumulation,” Neurology 96, no. 4 (2021): e619–31. PubMed PMC